Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia
Status:
Completed
Trial end date:
2018-01-10
Target enrollment:
Participant gender:
Summary
To demonstrate that the combination of daptomycin and fosfomycin is superior to daptomycin
alone in the treatment of methicillin resistant Staphylococcus aureus (MRSA) bacteremia.